910656-00-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyridinecarboxamide, 4-amino-N-methylis used as an intermediate in the synthesis of various pharmaceuticals for its potential therapeutic properties and ability to be incorporated into drug molecules.
Used in Agrochemical Industry:
3-Pyridinecarboxamide, 4-amino-N-methylis used as a building block in the development of agrochemicals, contributing to the creation of effective compounds for crop protection and enhancement.
Used in Fine Chemicals Production:
3-Pyridinecarboxamide, 4-amino-N-methylis utilized in the production of other fine chemicals, where its unique structure and properties can be leveraged for specific applications in various chemical processes.
It is important to handle 3-Pyridinecarboxamide, 4-amino-N-methylwith care, as it may pose health hazards if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 910656-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,0,6,5 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 910656-00:
(8*9)+(7*1)+(6*0)+(5*6)+(4*5)+(3*6)+(2*0)+(1*0)=147
147 % 10 = 7
So 910656-00-7 is a valid CAS Registry Number.
910656-00-7Relevant academic research and scientific papers
BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS
-
Page/Page column 93, (2011/02/24)
The present invention relates to benzoxazinone derivatives, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.
INHIBITORS OF FOCAL ADHESION KINASE
-
Page/Page column 128-129, (2008/12/07)
The invention provides inhibitors of focal adhesion kinase, an enzyme involved in the attachment of the cytoskeleton of a cell to an extracellular matrix, which has been implicated in processes such as cell migration, cell proliferation, and cell survival. The inhibitors are derivatives of a 5-substituted 2,4-diaminopyridine wherein the substituents are as defined herein. The invention also provides a method of using the inhibitors in treatment of cancer, and methods of preparation of the inhibitors by use of coupling reactions.
